Self-rated health predicts mortality and graft loss after kidney transplantation: A 10-year follow-up study

American Journal of Nephrology

Volumn 36, Issue 5, 2012, Pages 459-465

  Majernikova, Maria ^a   Rosenberger, Jaroslav ^a   Prihodova, Lucia ^a   Nagyova, Iveta ^a   Roland, Robert ^a,b   Groothoff, Johan W ^c   Van Dijk, Jitse P ^a,c  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Graft loss; Kidney transplantation; Mortality; Self rated health

Indexed keywords

ADULT; AGE; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; HEALTH STATUS; HEART FAILURE; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; SELF REPORT; SHORT FORM 36; SURGICAL PATIENT;

DIAGNOSTIC SELF EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; TIME FACTORS;

EID: 84868253252     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000343884     Document Type: Article

References (24)

1. Thong MS, Kaptein AA, Benyamini Y, et al: Association between a self-rated health question and mortality in young and old dialysis patients: a cohort study. Am J Kidney Dis 2008; 52:111-117.
2. DeSalvo KB, Bloser N, Reynolds K, et al: Mortality prediction with a single general self-rated health question. A meta-analysis. J Gen Intern Med 2006; 21: 267-275.
3. Mapes DL, Lopes AA, Satayathum S, et al: Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int 2003; 64:339-349.
4. Tsai YC: Quality of life predicts risks of endstage renal disease and mortality in patients with chronic kidney disease. Nephrol Dial Transplant 2010; 25:1621-1626.
5. Nissenson A, Chertow G, Farid M, et al: The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review. Hemodial Int 2009; 13: 347-359.
6. Sirivongs D, Liawnoraset W, Pongskul C, Reungjui S: Graft survival analysis in kidney transplantation: a 12-year experience in a Thai medical center. Transplant Proc 2004; 36:2034-2047.
7. Djamali A, Samaniego M, Torrealba J, et al: Increase in proteinuria 1200 mg/g after late rejection is associated with poor graft survival. Nephrol Dial Transplant 2010; 25: 1300-1306.
8. Schold JD, Srinivas TR, Howard RJ, et al: The association of candidate mortality rates with kidney transplant outcomes and center performance evaluations. Transplantation 2008; 85:1-6.
9. Nemati E: Prediction of inpatient survival and graft loss in rehospitalized kidney recipients. Transplant Proc 2007; 39: 974-977.
10. Ravindran V: Post-transplant diabetes mel-litus after renal transplantation: the emerging clinical challenge. Yonsei Med J 2004; 45: 1059-1064.
11. Novak M, Molnar MZ, Szeifert L, et al: Depressive symptoms and mortality in patients after kidney transplantation: a prospective prevalent cohort study. Psychosom Med 2010; 72: 527-534.
12. Wolfe RA, Ashby VB, Milford EL, et al: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
13. Laupacis A, Keown P, Pus N, et al: A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235-242.
14. Ware JE Jr, Sherbourne CD: The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-483.
15. McEwen LN: Are health-related quality-of-life and self-rated health associated with mortality? Insights from Translating Research Into Action for Diabetes (TRIAD). Prim Care Diabetes 2009; 3: 37-42.
16. Wight JP, Edwards L, Brazier J, et al: The SF-36 as an outcome measure of services for end-stage renal failure. Qual Health Care 1998; 7:209-221.
17. Franke GH, Reimer J, Philipp T, Heemann U: Aspects of quality of life through end-stage renal disease. Qual Life Res 2003; 12:103-115.
18. Gomez-Besteiro MI, Santiago-Perez MI, Alonso-Hernandez A, et al: Validity and reliability of the SF-36 questionnaire in patients on the waiting list for a kidney transplant and transplant patients. Am J Nephrol 2004; 24: 346-351.
19. Levey AS, Stevens LA: Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 2010; 55: 622-627.
20. Sis B, Mengel M, Haas M, et al: Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff Working Groups. Am J Transplant 2010; 10: 464-471.
21. Zhang R, Bowles T, Paintner P, Kutner N: Pretransplant physical functioning and kidney patients' risk for posttransplantation hospitalization/death: evidence from a national cohort. Clin J Am Soc Nephrol 2006; 1:837-843.
22. Cole EH, Johnston O, Rose CL, Gill JS: Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient sur viva l. Clin J Am Soc Nephrol 2008; 3: 814-821.
23. Tanikella R, Kawut SM, Brown RS, et al: Health-related quality of life and survival in liver transplant candidates. Liver Transpl 2010; 16:238-245.
24. Spiegel BM, Melmed G, Robbins S, Esrailian E: Biomarkers and health-related quality of life in end-stage renal disease: a systematic review. Clin J Am Soc Nephrol 2008; 3:1759-1768.